Kinemax Plus Revision TS Tibial Inserts 를 위한 안전성 경고 / 현장 안전성 서한

Medicines and Healthcare products Regulatory Agency에 따르면, 해당 안전성 경고 / 현장 안전성 서한 는 United Kingdom 에서 manufacturer #17429 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

현장 안전성 서한은 의료기기 제조사 또는 제조사 대리인이 시중에 유통되고 있는 자사 의료기기 제품에 대하여 취할 수 있는 조치를 알리는 소통방식입니다. 주요 대상층은 보건의료업계 종사자와 의료기기 사용자들입니다. 여기에는 회수(recall) 조치와 경고도 포함될 수 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert / Field Safety Notice
  • 사례 ID
    MDA/2008/066
  • 사례 연번
    CON025818
  • 날짜
    2008-09-18
  • 사례 국가
  • 사례 출처
    MHRA
  • 사례 출처 URL
  • 비고 / 경고
    Data from the United Kingdom is current through April 2019. All of the data comes from the Medicines and Healthcare products Regulatory Agency, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and the United Kingdom.
  • 데이터 추가 비고
  • 원인
    Risk of loosening, excessive wear and fracture of knee replacement components, due to a manufacturing defect. patients with revision knee replacements may have received a tibial insert with a manufacturing defect. the affected devices have an incorrectly machined stabiliser post recess, which prevents the tibial insert from fitting correctly over the stabiliser post. the manufacturer has contacted all uk users to recall the affected devices (see the manufacturer’s field safety notice in appendix). 112 affected devices were distributed in the uk. as a result of the recall, 73 unused devices have been returned to the manufacturer. the remaining 39 devices may have been implanted in patients. patients who have received these implants are at risk of loosening, excessive wear and/or fracture of components. these could be caused by any of the following reasons: the gap between components was not detected during assembly excessive force was required to seat the insert with the base plate a smaller stabiliser post from a smaller sized insert was used to complete the surgery.
  • 조치
    Do not implant affected devices Identify any affected stock that has not been implanted, and return to manufacturer Follow the patient management recommendations in this alert. Do not implant affected devices Identify any affected stock that has not been implanted, and return it to the manufacturer Identify which patients have been implanted with affected devices Ensure that affected patients, including those without symptoms, are followed up in accordance with usual standards of care for revision knee replacement patients (the manufacturer recommends follow-up at 6 weeks, 6 months, 12 months, and annually thereafter) Advise patients implanted with affected devices to report any increasing pain, or any symptoms of knee instability such as clicking Consider the need for revision for symptomatic patients.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Total knee replacement implants: Stryker Orthopaedics Kinemax Plus Revision TS Tibial Inserts (specific product and lot codes – see Appendix in pdf only).
  • Manufacturer

Manufacturer